EA201600336A3 - MEDICINE FOR PREVENTION AND TREATMENT OF BRAIN DISEASES AND METHOD FOR TREATING BRAIN DISEASES - Google Patents
MEDICINE FOR PREVENTION AND TREATMENT OF BRAIN DISEASES AND METHOD FOR TREATING BRAIN DISEASESInfo
- Publication number
- EA201600336A3 EA201600336A3 EA201600336A EA201600336A EA201600336A3 EA 201600336 A3 EA201600336 A3 EA 201600336A3 EA 201600336 A EA201600336 A EA 201600336A EA 201600336 A EA201600336 A EA 201600336A EA 201600336 A3 EA201600336 A3 EA 201600336A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- diseases
- brain diseases
- drug
- brain
- Prior art date
Links
- 208000014644 Brain disease Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 5
- 239000003814 drug Substances 0.000 abstract 5
- 201000010099 disease Diseases 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- 210000004556 brain Anatomy 0.000 abstract 2
- 208000032274 Encephalopathy Diseases 0.000 abstract 1
- HXDMOXJLUPTANA-ZCMDIHMWSA-N N(C(=O)C)[C@@H](C)CCC.CC1=CC=C(C(=N1)CC)O Chemical compound N(C(=O)C)[C@@H](C)CCC.CC1=CC=C(C(=N1)CC)O HXDMOXJLUPTANA-ZCMDIHMWSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области медицины и химико-фармацевтической промышленности, а именно - к лекарственному средству для лечения заболеваний головного мозга и способу лечения таких заболеваний. Заявлено лекарственное средство, содержащее в качестве активного ингредиента 6-метил-2-этилпиридин-3-ол соль (2S)-2-ацетаминопентандиовой кислоты в фармакологически эффективной дозе, для лечения и/или профилактики заболеваний головного мозга, в частности острых нарушений мозгового кровообращения и энцефалопатии различного генеза, а также способ лечения указанных заболеваний с использованием указанного лекарственного средства. Заявленная группа изобретений позволяет расширить арсенал средств для лечения заболеваний головного мозга, а также усилить фармакологическую активность при одновременном снижении лекарственной нагрузки на пациента.The invention relates to the field of medicine and the pharmaceutical industry, namely to the drug for the treatment of diseases of the brain and the method of treatment of such diseases. Stated drug containing as active ingredient 6-methyl-2-ethylpyridin-3-ol salt (2S) -2-acetaminopentane acid in a pharmacologically effective dose, for the treatment and / or prevention of brain diseases, in particular acute disorders of cerebral circulation and encephalopathy of various origins, as well as a method of treating these diseases using the specified drug. The claimed group of inventions allows you to expand the Arsenal of tools for the treatment of diseases of the brain, as well as to enhance the pharmacological activity while reducing the drug load on the patient.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2015108665A RU2692063C2 (en) | 2015-03-12 | 2015-03-12 | Medicinal agent for preventing and treating cerebral diseases and method of treating cerebral diseases |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201600336A2 EA201600336A2 (en) | 2016-09-30 |
EA201600336A3 true EA201600336A3 (en) | 2016-12-30 |
EA036126B1 EA036126B1 (en) | 2020-10-01 |
Family
ID=53611501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201600336A EA036126B1 (en) | 2015-03-12 | 2016-02-25 | Method of treating cerebral diseases |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA036126B1 (en) |
RU (1) | RU2692063C2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA020800B1 (en) * | 2012-11-09 | 2015-01-30 | Замертон Холдингс Лимитед | Pharmaceutical composition having a neuroprotective, nootropic, antiamnesic effect, and method for preventing and/or treating states associated with cerebral circulation disorders, cerebrovascular and neurodegenerative diseases |
-
2015
- 2015-03-12 RU RU2015108665A patent/RU2692063C2/en active
-
2016
- 2016-02-25 EA EA201600336A patent/EA036126B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2015108665A (en) | 2015-07-20 |
EA201600336A2 (en) | 2016-09-30 |
RU2692063C2 (en) | 2019-06-20 |
RU2015108665A3 (en) | 2018-10-24 |
EA036126B1 (en) | 2020-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202090955A1 (en) | METHODS OF USING EHMT2 INHIBITORS IN TREATMENT OR PREVENTION OF BLOOD DISORDERS | |
MX2021000071A (en) | Use of pridopidine to improve cognitive function and for treating alzheimer's disease. | |
ECSP18073366A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
BR112015009948A8 (en) | Activin-actrii antagonists, uses thereof for treating bone diseases and other disorders, and method for monitoring the effectiveness of treating or preventing a bone disease and other disorders | |
MX2019012884A (en) | Combination therapy. | |
MX2022003072A (en) | Use of pridopidine for treating functional decline. | |
EA201591535A1 (en) | SUBSTITUTED DERIVATIVES OF 3-PHENYL-PROPYLAMINE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES AND DISORDERS | |
BR112015010396A2 (en) | combination therapy | |
MX2021002321A (en) | Novel methods. | |
EA201991374A1 (en) | WATER-SOLUBLE DERIVATIVE OF EPIALLOPRANANOLONE AND ITS APPLICATION | |
MA39447A1 (en) | (s) -pirlindole or its pharmaceutically acceptable salts for use in medicine | |
UA109359C2 (en) | TREATMENT OF SKIN DISEASES AND STATES | |
MD4763C1 (en) | Pharmaceutical composition | |
BR112018067663A2 (en) | sulfamate-derived compounds, processes for their preparation and their uses | |
EA201600336A2 (en) | MEDICINE FOR PREVENTION AND TREATMENT OF BRAIN DISEASES AND METHOD FOR TREATING BRAIN DISEASES | |
BR112014032264A8 (en) | Composition for the treatment or prevention of diseases related to vascular permeability, containing imatinib or a pharmaceutically acceptable salt thereof as an active ingredient | |
BR112015026484A2 (en) | treatment or prevention of noninflammatory neuronal damage from brain trauma and strokes using menthol, linalool and / or icilin | |
EA202090416A1 (en) | METHODS FOR TREATING GASTROPARESIS SYMPTOMS USING A VELUSETRAGA | |
CL2018000085A1 (en) | Heteroaryl carbonitriles for the treatment of diseases | |
BR112018072583A2 (en) | stable tablet tablet pharmaceutical composition | |
UA111462C2 (en) | Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication | |
BR112018002433A2 (en) | pharmaceutical composition for migraine treatment | |
AR101227A1 (en) | COMBINATIONS OF A N-TIAZOLIL-4-PHENOXIBENCENOSULFONAMIDE DERIVATIVE AND A PHARMACEUTICALLY ACTIVE AGENT SELECTED FROM GABAPENTINE AND PREGABALINE TO TREAT PAIN | |
MX2018002786A (en) | Vinpocetine pharmaceutical composition. | |
EA201990553A1 (en) | APPLICATION OF PRIDOPIDIN FOR TREATMENT OF FUNCTIONAL ABILITY |